Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers | FDA

Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing - Letter to Health Care Providers | FDA

Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing: Letter to Health Care Providers

The U.S. Food and Drug Administration (FDA) recommends that health care providers give clear, step-by-step instructions to patients who, in a health care setting, are self-collecting anterior nasal samples for SARS-CoV-2 testing. Without proper instructions, patients may not collect an adequate sample for testing, which may decrease the sensitivity of the test.

Read More

The Letter to Health Care Providers includes:

• Details for providing patients with clear instructions for performing anterior nares (nasal) sample self-collection in a health care setting
• Recommendations for health care providers
• Suggested resources on testing for SARS-CoV-2
• Instructions for reporting problems with a device

Questions?

If you have questions about this Letter to Health Care Providers, email COVID19DX@fda.hhs.gov.